Section R12-1-722. Safety Instruction and Precautions for Use of Unsealed Radioactive Material Requiring a Written Directive

A.      A licensee shall provide radiation safety instruction, initially and at least annually, for all personnel caring for the patient or human research subject receiving radiopharmaceutical therapy and hospitalized for compliance with R12-1-717. To satisfy this requirement, the instruction shall describe the licensee’s procedures for:

1.        Patient or human research subject control;

2.        Visitor control;

3.        Contamination control;

4.        Waste control; and

B.       For each patient or human research subject who cannot be released under R12-1-717, a licensee shall:

1.        Quarter the patient or the human research subject in a pri- vate room with a private sanitary facility;

2.        Visibly post the patient’s or the human research subject’s room with a “Radioactive Materials” sign.

3.        Note on the door or in the patient’s or human research subject’s chart where and how long visitors may stay in the patient’s or the human research subject’s room; and

4.        Monitor material and items removed from the patient’s or the human research subject’s room to determine that their radioactivity cannot be distinguished from the natural background radiation level with a radiation detection sur- vey instrument set on its most sensitive scale and with no interposed shielding, or handle the material and items as radioactive waste.

C.      A licensee shall notify the radiation safety officer, or his or her designee, and the authorized user as soon as possible if the patient or human research subject has a medical emergency or dies.

D.      A licensee shall retain records of instruction and safety proce- dures performed under this rule for three years from the date of the activity.

Historical Note

New Section made by final rulemaking at 13 A.A.R.

1217, effective May 5, 2007 (Supp. 07-1).